Alexander, V. N., V. Northrup, and M. J. Bizzarro. 2011. Antibiotic exposure in the newborn intensive care unit and the risk of necrotizing enterocolitis. Journal of Pediatrics 159(3):392-397.

Al-Qutub, M. N., P. H. Braham, L. M. Karimi-Naser, X. Liu, C. A. Genco, and R. P. Darveau. 2006. Hemin-dependent modulation of the lipid A structure of Porphyromonas gingivalis lipopolysaccharide. Infection and Immunity 74(8):4474-4485.

Antonopoulos, D. A., S. M. Huse, H. G. Morrison, T. M. Schmidt, M. L. Sogin, and V. B. Young. 2009. Reproducible community dynamics of the gastrointestinal microbiota following antibiotic perturbation. Infection and Immunology 77(6):2367-2375.

Bartlett, J. G., A. B. Onderdonk, R. L. Cisneros, and D. L. Kasper. 1977. Clindamycin-associated colitis due to a toxin-producing species of clostridium in hamsters. Journal of Infectious Diseases 136(5):701-705.

Brown, C. T., A. G. Davis-Richardson, A. Giongo, K. A. Gano, D. B. Crabb, N. Mukherjee, G. Casella, J. C. Drew, J. Ilonen, M. Knip, H. Hyoty, R. Veijola, T. Simell, O. Simell, J. Neu, C. H. Wasserfall, D. Schatz, M. A. Atkinson, and E. W. Triplett. 2011. Gut microbiome metagenomics analysis suggests a functional model for the development of autoimmunity for type 1 diabetes. PLoS ONE 6(10):e25792.

Chang, J. Y., D. A. Antonopoulos, A. Kalra, A. Tonelli, W. T. Khalife, T. M. Schmidt, and V. B. Young. 2008. Decreased diversity of the fecal microbiome in recurrent clostridium difficile-associated diarrhea. Journal of Infectious Diseases 197(3):435-438.

Chen, X., K. Katchar, J. D. Goldsmith, N. Nanthakumar, A. Cheknis, D. N. Gerding, and C. P. Kelly. 2008. A mouse model of Clostridium difficile-associated disease. Gastroenterology 135(6):1984-1992.

Clark, R. H., B. T. Bloom, A. R. Spitzer, and D. R. Gerstmann. 2006. Reported medication use in the neonatal intensive care unit: Data from a large national data set. Pediatrics 117(6):1979-1987.

Coats, S. R., T. T. Pham, B. W. Bainbridge, R. A. Reife, and R. P. Darveau. 2005. Md-2 mediates the ability of tetra-acylated and penta-acylated lipopolysaccharides to antagonize Escherichia coli lipopolysaccharide at the tlr4 signaling complex. Journal of Immunology 175(7):4490-4498.

Coats, S. R., C. T. Do, L. M. Karimi-Naser, P. H. Braham, and R. P. Darveau. 2007. Antagonistic lipopolysaccharides block E. coli lipopolysaccharide function at human tlr4 via interaction with the human md-2 lipopolysaccharide binding site. Cell Microbiology 9(5):1191-1202.

Darveau, R. P. 2009. The oral microbial consortium’s interaction with the periodontal innate defense system. DNA and Cell Biology 28(8):389-395.

———. 2010. Periodontitis: A polymicrobial disruption of host homeostasis. Nature Reviews Microbiology 8(7):481-490.

Darveau, R. P., C. M. Belton, R. A. Reife, and R. J. Lamont. 1998. Local chemokine paralysis, a novel pathogenic mechanism for Porphyromonas gingivalis. Infection and Immunology 66(4):1660-1665.

DiGiulio, D. B., R. Romero, H. P. Amogan, J. P. Kusanovic, E. M. Bik, F. Gotsch, C. J. Kim, O. Erez, S. Edwin, and D. A. Relman. 2008. Microbial prevalence, diversity and abundance in amniotic fluid during preterm labor: A molecular and culture-based investigation. PLoS ONE 3(8):e3056.

Dominguez-Bello, M. G., E. K. Costello, M. Contreras, M. Magris, G. Hidalgo, N. Fierer, and R. Knight. 2010. Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. PNAS 107(26):11971-11975.

The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement